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Autophagy in the Eye: Implications for Ocular Cell Health
Abstract
Autophagy, a catabolic process by which a cell "eats" itself, turning over its own cellular constituents,
plays a key role in cellular homeostasis. In an effort to maintain normal cellular function, autophagy is
often up-regulated in response to environmental stresses and excessive organelle damage to facilitate
aggregated protein removal. In the eye, virtually all cell types from those comprising the cornea in the
front of the eye to the retinal pigment epithelium (RPE) providing a protective barrier for the retina at the
back of the eye, rely on one or more aspects of autophagy to maintain structure and/or normal
physiological function. In the lens autophagy plays a critical role in lens fiber cell maturation and the
formation of the organelle free zone. Numerous studies delineating the role of Atg5, Vsp34 as well as
FYCO1 in maintenance of lens transparency are discussed. Corneal endothelial dystrophies are also
characterized as having elevated levels of autophagic proteins. Therefore, novel modulators of autophagy
such as lithium and melatonin are proposed as new therapeutic strategies for this group of dystrophies.
In addition, we summarize how corneal Herpes Simplex Virus (HSV-1) infection subverts the cornea's
response to infection by inhibiting the normal autophagic response. Using glaucoma models we analyze
the relative contribution of autophagy to cell death and cell survival. The cytoprotective role of autophagy
is further discussed in an analysis of photoreceptor cell heath and function. We focus our analysis on the
current understanding of autophagy in photoreceptor and RPE health, specifically on the diverse role of
autophagy in rods and cones as well as its protective role in light induced degeneration. Lastly, in the RPE
we highlight hybrid phagocytosis-autophagy pathways. This comprehensive review allows us to speculate
on how alterations in various stages of autophagy contribute to glaucoma and retinal degenerations. ©
2014 Elsevier Ltd.
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Autophagy, a catabolic process by which a cell “eats” itself, turning over its own cellular constituents,
plays a key role in cellular homeostasis. In an effort to maintain normal cellular function, autophagy is
often up-regulated in response to environmental stresses and excessive organelle damage to facilitate
aggregated protein removal. In the eye, virtually all cell types from those comprising the cornea in the
front of the eye to the retinal pigment epithelium (RPE) providing a protective barrier for the retina at the
back of the eye, rely on one or more aspects of autophagy to maintain structure and/or normal physiological function. In the lens autophagy plays a critical role in lens ﬁber cell maturation and the formation of the organelle free zone. Numerous studies delineating the role of Atg5, Vsp34 as well as FYCO1
in maintenance of lens transparency are discussed. Corneal endothelial dystrophies are also characterized as having elevated levels of autophagic proteins. Therefore, novel modulators of autophagy such as
lithium and melatonin are proposed as new therapeutic strategies for this group of dystrophies. In
addition, we summarize how corneal Herpes Simplex Virus (HSV-1) infection subverts the cornea’s
response to infection by inhibiting the normal autophagic response. Using glaucoma models we analyze
the relative contribution of autophagy to cell death and cell survival. The cytoprotective role of autophagy is further discussed in an analysis of photoreceptor cell heath and function. We focus our analysis
on the current understanding of autophagy in photoreceptor and RPE health, speciﬁcally on the diverse
role of autophagy in rods and cones as well as its protective role in light induced degeneration. Lastly, in
the RPE we highlight hybrid phagocytosiseautophagy pathways. This comprehensive review allows us to
speculate on how alterations in various stages of autophagy contribute to glaucoma and retinal
degenerations.
Ó 2014 Elsevier Ltd. All rights reserved.
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1. Introduction
Autophagy is the major eukaryotic degradative process for
cytosolic organelles, long-lived proteins as well as misfolded protein aggregates, playing an important role in development, adaptation, starvation, tumor suppression, and aging as well as innate
and adaptive immunity. Although mostly referred to strictly as a
degradative process, autophagy is also often described as a renewal
process; a pathway by which metabolites generated through
autophagic degradation are reused either as sources of energy or
building blocks for synthesis of new macromolecules.
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Macro-autophagy hereafter referred to as autophagy is the
primary mechanism by which cells ‘self-eat’ delivering sequestered
cytosolic cargo to lysosomes for proteolytic degradation by lysosomal proteases (Xie and Klionsky, 2007). Sequestration vesicles,
known as autophagosomes, form through a highly regulated
pathway requiring over 20 autophagy related proteins (Atg)
(Thumm et al., 1994; Tsukada and Ohsumi, 1993). Canonical autophagosome (AP) formation is evolutionarily conserved, requiring
initiation (1), nucleation (2), elongation and closure (3), as illustrated in Fig. 1, with the key proteins essential at each stage indicated (Mizushima et al., 2011). In addition, there is a recycling stage
as well as the ﬁnal degradative stage. The initiation stage requires a
UNC51-like kinase (ULK1) containing complex consisting of the
kinase and its substrates, Atg13 and FIP200. ULK1 activity is stimulated by AMP-activated protein kinase (AMPK, in response to
increased AMP/ATP ratios) and inhibited by mammalian target of
rapamycin complex 1 (mTORC1). Critical in the nucleation stage is a
protein complex consisting of BCL-2 interacting myosin/moesin-
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regulated interplay between basal and stress induced autophagic
pathways. In this review we focus our attention on the current
understanding of the role of autophagy in the health and pathology
of the lens, cornea, photoreceptor and RPE, and emphasize the
proposed role of this degradative pathway in glaucoma and retinal
degenerative disease.
2. Autophagy in the lens

Fig. 1. Basic autophagic processes. The stages of autophagosome formation are illustrated. Autophagosome formation, an evolutionarily conserved process utilizes an
Initiation stage (1), a Nucleation stage (2) as well as an Elongation and Closure stage
(3), ultimately the degradation of autophagosomal content proceeds through fusion of
autophagosome with lysosome in an autolysosome in a degradation stage. 1. The mTOR
complex (shown as mTORC1) represses autophagy when amino acids energy and
growth factors are abundant through the inhibition of ULK1 activity. Upon energy
deprivation the Initiation Stage commences through the stimulation of Ulk1 kinase
activity and phosphorylation of its substrates Atg13 and FIP100. Rapamycin removes
the mTOR mediated inhibition of autophagy 2. During the nucleation stage, the generation of PtdIns3P by the Vsp34 allows for the recruitment of additional factors. The
functional relationship between the individual components of the initiation stage and
nucleation stage is unclear. 3. The expansion and subsequent closure of the autophagosome depends on the Atg5/Atg12 conjugate system which facilitates the lipidation of
LC3 to LC3II by phosphatidylethanolamine (PE).

like coiled-coiled protein (Beclin1), the phosphatidylinositol 3kinase called Vsp34, and Atg14. During this stage, the Beclin1e
Vsp34eAtg14 complex mediated production of PtdIns3P recruits
WIPI1 and Atg2 (Walker et al., 2008) in the formation of a nascent
autophagosome. Subsequently, autophagosome elongation and
closure requires an Atg7 dependent Atg12eAtg5 conjugation system that is responsible for the lipidation, by phosphatidylethanolamine (PE), of microtubule-associated protein 1 light chain 3
(LC3). Lipids are supplied to the expanding autophagosomal
membrane via an Atg9 dependent pathway. Closure of the autophagosome ensures complete inclusion of the autophagosome
cargo. Ultimately, degradation of this cargo relies upon the autophagosome’s association and fusion with lysosomes in a structure
referred to as an autolysosomes. A component of this process, the
FYVE coiled-coil domain containing 1 (FYCO1) protein functions as
a Rab7 effector to mediate the microtubule dependent transport of
autophagic vacuoles (Pankiv et al., 2010). Details of the individual
stages can be found in several excellent reviews (Boya et al., 2013;
Codogno et al., 2011; Mehrpour et al., 2010).
In the eye, virtually all cell types cells from those comprising the
cornea in the front of the eye to the retinal pigment epithelium
(RPE) providing a protective barrier for the retina at the back of the
eye, rely on one or more aspects of autophagy to maintain structure
and/or normal physiological function. The essentiality of autophagic processes for healthy vision is best illustrated by a comparison
of autophagy related proteins expressed in various cells of the eye.
Gene mutations in some of these contribute directly to ocular
disease, while in other cases cellular homeostasis relies on

The lens is comprised of a layer of simple cuboidal epithelium at
the anterior pole that continues to differentiate at the equatorial
region to form ﬁber cells. Upon maturation, these differentiating
ﬁber cells lose their organelles to produce the organelle free zone
(OFZ) thus contributing to lens transparency. Congenital cataracts
may result from the improper clearance of proteins and organelles
producing lens opacity. Consistent with a role for autophagy in lens
organelle degradation, mutations in the FYCO1 gene were identiﬁed as a cause of autosomal recessive congenital cataracts (Chen
et al., 2011). FYCO1 is a PI(3)P, Rab7 and LC3 binding protein that
mediates microtubule plus end-directed vesicle transport of autophagosomes, a process essential in autolysosome formation (Pankiv
et al., 2010). FYCO1 was one of 40þ autophagy genes identiﬁed and
characterized by Brennan et al. (2012), in a comprehensive analysis
of autophagy gene and protein expression. Autophagy genes associated with all stages of autophagy, including, initiation, autophagosome elongation and closure as well as autolysosomal
degradation were found in lens epithelium and ﬁbers. LC3 and
FYCO1 were expressed throughout the newborn mouse lens, in
both the lens epithelium and ﬁber cells with highest levels detected
in nuclear ﬁbers suggesting that autophagy plays a role in lens ﬁber
cell differentiation (Brennan et al., 2012). These studies also document an elevation of LC3II in the human lens ﬁber cells measured as
an increased number of LC3 positive autophagosomes, under stress
conditions. These authors did not directly measure autophagic ﬂux.
Consistent with the hypothesis that dysfunctional FYCO1 may
contribute to altered autophagy and lens opacity are studies by
Chen et al. (2011) who document the partial co-localization of
FYCO1 with LC3 enriched vesicles, albeit they present no conﬁrmatory immuno-EM analysis.
Costello et al. (2013), suggest that autophagy is a key process
involved in lens ﬁber cell maturation and formation of the OFZ.
They demonstrate, by EM and confocal microscopy, the presence of
autophagic vesicles in embryonic and adult lens (Costello et al.,
2013). In these cells, serum starvation results in increased colocalization of mitochondria and autophagy markers, suggesting that
the lens cells can respond to environmental stress through the
induction of autophagy and mitophagy (the selective removal of
mitochondria by autophagy). Collectively, these studies are
consistent with the hypothesis that FYCO1 is required for organelle
degradation and lens epithelial cell differentiation. FYCO1 is
expressed in both the embryonic and adult lens where it localizes
to autophagosomes and lysosomes. The loss of FYCO1 may inhibit
transport of APs to lysosomes resulting in an accumulation of LC3II
positive vesicles and ultimately lead to a loss of lens transparency.
Furthermore, they support the idea that loss of lens resistance to
stress may result in cataract formation.
In studies focused on events upstream of LC3 lipidation, speciﬁcally the role of the Atg5/Atg12 complex in lens organelle
degradation, Matsui et al. (2006), observe autophagic vacuoles in
lens epithelial cells, however they demonstrate that organelle
degradation in lens cells occurs normally in the absence of Atg5, in
the Atg5/ mouse (Matsui et al., 2006). While these studies are
important in understanding the role of Atg5 in lens development,
they provide little insight into the role of autophagy in long-term
lens homeostasis given that the Atg5/ mice die only 10 h after
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birth. This lethality problem was overcome in studies using lens
speciﬁc ablation of Atg5 in Atg5ﬂox/ﬂox;MRL10-Cre mice, Morishita
et al. (2013), show that Atg5 is required for the suppression of
age-related cataracts but has no effect on programmed organelle
degradation. Thus the authors posit that Atg5 is correlated with age
related cataract likely through compromised intracellular quality
control due to the accumulation of p62, oxidized proteins and
insoluble crystalins in an autophagy independent manner
(Morishita et al., 2013). In the context of these studies it is important to note several recent studies that suggest autophagosome
elongation may occur in an Atg5-independent pathway utilizing
instead the monomeric rabGTPase, Rab9, for elongation and
closure. The resulting non-canonical double membrane autophagosome can serve to degrade and recycle cargo as need during lens
development and cell homeostasis (Ao et al., 2014; Codogno et al.,
2011).
Vsp34, a class III phosphatidylinositol 3-kinase, is involved in an
Atg5-independent autophagy pathway that depends on upstream
autophagic events requiring Ulk1 (see Fig. 1) (Nishida et al., 2009);
Vsp34 also complexes with beclin1. To determine if lens organelle
degradation utilized a non-canonical pathway requiring Vsp34 and
independent of Atg5, a lens-speciﬁc Vps34 deletion was analyzed.
The loss of Vsp34 did not affect lens organelle degradation suggesting cataract formation is not due to disrupted autophagy
initiation (Morishita et al., 2013). Loss of Vsp34, however did lead to
congenital cataracts and defective lens development.
Connexins are the building blocks of gap junctions; their short
half-life suggests that their degradation and renewal is critical in
maintaining cellecell contacts. CX50 is a connexin expressed
speciﬁcally in the lens, and the CX50 P88S mutant has been shown
to be associated with inherited congenital cataracts. Lichtenstein
et al. (2011) verify that CX50 colocalizes with LC3 and demonstrate that starvation leads to decreased wild-type connexin
levels. Inhibition of autophagy by ATG5 knockdown decreases this
effect (Lichtenstein et al., 2011). The mutant connexin, CX50 P88S,
also accumulates and colocalizes with autophagy markers ultimately being degraded after starvation. These studies suggest that
autophagy can regulate both wild-type connexin levels and
mutant, CX50 P88S accumulation. Mediation of autophagy could
therefore be an appropriate strategy to ameliorate disease pathogenesis. However, as Lichtenstein et al. (2011) suggest autophagic degradation is not the complete story; although lysosomes are
involved in starvation-induced autophagy the starvation-induced
degradation of WT connexins is only partially dependent on
lysosome activity as treatment with chloroquine to alkalinize lysosomes and inactivate degradative lysosomal enzymes does not
completely prevent the starvation-induced decrease in connexin
levels.
The autophagy related studies reviewed here underscore the
need to understand how autophagic degradation and likely even
more importantly metabolic and macromolecular constituent
renewal contribute to lens development and later to lens homeostasis and transparency. This is especially important given the post
mitotic nature of the lens ﬁber cells which must adapt to a lifetime
of stressors. Multiple converging and redundant degradative
pathways have been suggested as necessary for long term control of
organelle degradation and lens transparency (Wride, 2011). As such
autophagy is one of many lysosome mediated clearance mechanisms and emphasis on the interplay between several converging
degradative mechanisms using in vivo models when possible will
provide valuable insight into how speciﬁc disruptions in autophagy
contributes to disease. It is important to note that while several
studies demonstrate increases in LC3II by Western blot few look at
autophagy induction or autophagic ﬂux using conventional autophagy assays employing baﬁlomycin A1, DQ-BSA or chloroquine for

example (Ha et al., 2010; Klionsky et al., 2008a, 2008b; Vazquez and
Colombo, 2009).
3. Autophagy in the cornea
Corneal endothelial dystrophies are characterized by the progressive degeneration of corneal endothelium, due in part to genetic predisposition (Schmedt et al., 2012). Granular corneal
dystrophy type 2 (GCD2) is caused by a point mutation in the
Transforming Growth Factor Beta 1 (TGFb1) gene resulting in agedependent accumulation of aggregated proteins in the corneal
epithelia and stroma, which interferes with corneal transparency
(Choi et al., 2011). The TGFb1 protein is a critical component of the
extracellular matrix (ECM), mediating cell adhesion and migration
through integrins. Analysis by Choi et al. (2012) reveals that the
aggregate prone mutant TGFb1 protein extensively colocalizes with
LC3 enriched vesicles and requires autophagy for its clearance (Choi
et al., 2012). Although LC3II was increased in GCD2 corneal ﬁbroblasts, the LC3II levels were unaltered upon treatment with the
vacuolar Hþ-ATPase inhibitor, baﬁlomycin A1, known to block
fusion of autophagosomes with lysosomes. Treatment with the
proteasome inhibitor MG132 coupled with ubiquitin immunoblot
analysis suggests that TGFb1 clearance does not involve the
ubiquitin/proteasome-dependent pathway allowing the authors to
infer that autophagy is the main intracellular degradation system.
Consistent with this interpretation, enhancing autophagy with
rapamycin to inhibit the negative regulator of autophagy, mTOR,
led to decreased levels of mutant TGFb1 suggesting defective
autophagy may contribute to the pathogenesis of GCD2 (Choi et al.,
2012).
In addition to rapamycin, lithium also enhances autophagy and
is proposed in the treatment of neurodegenerative diseases in
which the toxic protein is an autophagy substrate. Lithium induces
autophagy in an mTOR independent pathway that likely inhibits
inositol monophosphatase thus affecting the autophagy pathway at
a point downstream of decreased myo-inositol-1,4,5-triphosphate
(IP3) levels (Sarkar et al., 2005). In the presence of lithium there
is reduced expression of TGFb1 protein with a concomitant increase
in the ratio of LC3II:I in corneal ﬁbroblasts (Choi et al., 2011). Based
on these observations Choi et al., 2011, suggest that lithium mediated modulation of autophagy could be used in the treatment of
GCD2. Data on the autophagic ﬂux in these cells would strengthen
the rationale for lithium as a potential therapeutic approach.
Modulation of autophagy as a GCD2 therapeutic is further supported in studies by Choi et al. (2013a, 2013b) in which they
document a melatonin mediated induction of autophagy in an
mTOR dependent manner, resulting in increased beclin-1 levels.
Melatonin activates autophagy in both wild type and GCD2 ﬁbroblasts, consequently eliminating mutant TGFb1 in GCD corneal ﬁbroblasts with a combination of rapamycin and melatonin having
an additive effect on mutant TGFb1 protein clearance (Choi et al.,
2013b).
Fuchs endothelial corneal dystrophy (FECD), characterized by a
decrease in corneal endothelial cell (CEC) density, ECM deposits,
and thickening of the Descemet basement membrane of the CEC,
has also been linked to alterations in autophagic processes. The
primary component of the basement membrane is collagen type
VIII, thus it is not surprising that the Col8a2 Q455K knock-in mouse
exhibits a FECD-like endothelial morphology and is used as a model
of early onset disease (Matthaei et al., 2013). Morphological and
molecular analysis of the Col8a2 Q455K mouse reveals an increase
in damage-regulated autophagy modulator Dram1, a p53 target
gene encoding a lysosomal protein that induces macroautophagy
(Meng et al., 2013). These studies also document an increase in LC3
with a decrease in Atg12eAtg5 in mutant endothelium compared
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to age matched controls. Transmission electron microscopy (TEM)
identiﬁes large vacuoles containing partially degraded organelles,
suggesting altered degradation. The relevance of these ﬁndings to
human disease is reinforced by the observation that human FECD
patients exhibit a 10.4 fold increase in DRAM1 gene expression,
although protein levels have not been measured. Although
compelling, these human studies are largely correlative and would
beneﬁt from an assessment of defects in AP formation at the ultrastructural level in human FECD donor cells, or further analysis of
autophagy ﬂux (fusion of the AP with the lysosome, and subsequent protein degradation) in the Col8a2 Q455K knock-in mouse.
Autophagy is also critical for the degradation of invading microorganisms in a process known as xenography (Deretic, 2005;
Deretic and Levine, 2009), albeit numerous microorganisms subvert this normal response to persist and survive (Krummenacher
et al., 2011). The human cornea is a primary target for herpes
simplex infection (HSV-1), which enters endothelial cells through
endocytosis (Shah et al., 2010). Entry of herpes simplex into target
cells is complex and proceeds by a sequential succession of interactions between 5 viral envelope glycoproteins (designated gB,
gC, gD, gH and gL) and receptors on the cell membrane. After
attachment to the cell (gC), there is an interaction with a speciﬁc
entry receptor (gD), followed by internalization of the virion, and
membrane fusion (gB, and gH/gL). The viral genome is then delivered to the cell nucleus to initiate viral replication (Eisenberg et al.,
2012; Krummenacher et al., 2013). The corneal pathogen HSV-1
actively inhibits autophagy through interactions with the autophagy promoting protein beclin-1. In the host cell, beclin-1 through
its association with Vsp34 is necessary in the formation of autophagosomes (Fig. 1). Using a murine model of corneal HSV-1
infection, Leib et al. (2009), demonstrate that the HSV gene product, ICP34.5, antagonizes the normal autophagic response through
its interaction with beclin-1 via a beclin binding domain (BBD).
These investigators generated two recombinant HSV-1 viruses,
recombinant virus D68H in which the beclin1 binding domain was
deleted and its marker counterpart 68HR. Both D68H and D68HR
replicated at similar rates early in infection however, D68H was
cleared more rapidly after corneal infection, leading to less ocular
disease. The authors propose that enhanced clearance is due to
autophagy mediated degradation. Using the same recombinant
HSV-1 viruses, Zhang et al. (2013), sought to determine how loss of
the beclin binding domain affects viral ocular infection by following
the spread of D68H and D68HR from the eye to the brain after
anterior chamber inoculation. Mice injected with D68H showed
enhanced conversion of LC3 to LCII in both the eye and brain 4e6
days post infection. This elevation in LC3II was interpreted by the
authors as enhanced autophagy, though again autophagic ﬂux was
not measured. D68H infection also led to NLRP3 inﬂammasome
activation, measured as cleavage of caspase 1, leading to an
enhanced innate immune response. Both D68H and D68HR
appeared to replicate equivalently in the injected eyes, however,
less severe ipsilateral retinal infection was observed with D68H
than in eyes injected with D68HR. Collectively, these studies suggest that autophagy’s role in controlling HSV-1 infection is via a
more rapid induction of the innate immune response. Whether
inﬂammasome activation occurs through an autophagy dependent
mechanism remains to be determined.
4. Glaucoma and autophagy
Glaucomas, are a group of eye diseases characterized by the
progressive degeneration of the optic nerve and, are the second
leading cause of permanent blindness. Primary Open Angle Glaucoma (POAG), the most prevalent form of the disease, is a late onset
disorder often associated with an increase in intraocular pressure
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(IOP), that likely results from failure of the trabecular meshwork
(TM) to maintain aqueous humor outﬂow at an appropriate rate
(Athanasiou et al., 2013). Decreased aqueous humor outﬂow results
in increased IOP which can eventually result in damage to the optic
nerve head and retinal ganglion cells (RGCs).
The TM lies between the cornea and sclera and consists of
collagen and elastin beams surrounded by endothelial-like cells.
TM cells are post-mitotic, differentiated cells with a low proliferative capacity (Liton et al., 2009). The post-mitotic nature of these
cells highlights the critical need to efﬁciently remove damaged
organelles and misfolded proteins to avoid toxicity and degeneration. Cells in the TM are exposed to a considerable level of reactive
oxygen species (ROS) resulting in the accumulation of nondegradable material in lysosomes and a decrease in lysosome activity (Liton et al., 2009). Lysosomal alkalinization is accompanied
by a decrease in autophagic ﬂux in stressed TM cells (Porter et al.,
2013), ultimately, leading to a decline in TM cell function and the
progression of POAG.
While autophagy is often associated with cell death, RodriguezMuela et al. (2012) suggest that autophagy can promote the survival
of RGCs after optic nerve axotomy (Rodriguez-Muela et al., 2012).
Optic nerve axotomy is an acute model for RGC death in glaucoma,
and axotomy was found to increase autophagic processes at both
the mRNA and protein levels, with detection of an increase in GFPLC3 puncta and double-membrane bound autophagosomes by EM.
Axotomy in RGC-speciﬁc Atg5 knockout mice results in increased
cell death versus the wild-type control, while rapamycin treatment
decrease the RGC loss, both suggesting autophagy promotes cell
survival in the axotomy model. This result is not unexpected given
that axotomy of peripheral neurons and motor neurons can lead to
a robust regenerative response without any neuronal death
(Rubinsztein et al., 2005).
Mutations in the optineurin (OPTN) gene are associated with
normal-tension glaucoma (Rezaie et al., 2002), a disorder where
RGCs are lost in a pattern analogous to that in POAG but with the
IOP within normal range. E50K is the most common disease causing
mutation of optineurin (Chalasani et al., 2007), and overexpression
of the optineurin E50K mutation in mice led to a loss of RGCs and
other retinal cell types with no change in IOP (Chi et al., 2010).
Optineurin was identiﬁed as an autophagy receptor involved in the
elimination of cytosolic bacteria (Wild et al., 2011). Wild and coworkers identiﬁed a LC3-interacting motif (LIR) in optineurin,
documenting its localization to LC3-positive structures upon induction of autophagy. Semi-quantitative immunohistochemistry
suggested an increase in LC3 levels in the RGCs of mice overexpressing OPTNE50K (Shen et al., 2011). While this study also
demonstrated rapamycin was protective in RGC5 cells overexpressing E50K, the unresolved nature of the RGC5 cells, combined with the loss of several retinal cell types in the mouse
overexpressing E50K, makes the relevance to glaucoma difﬁcult to
interpret. Whether autophagy protects RGCs by speciﬁc degradation and elimination of accumulated mutant proteins such as OPTN
and its binding partners is an important hypothesis, however. In
this regard, Tezel et al. (2012a, 2012b) ﬁnd POAG patient serum
samples contain optineurin and huntingtin thought to be due to
failure of autophagic proteolytic fragmentation (Tezel et al., 2012a).
In contrast to the protective contribution of autophagy, Park
et al. (2012) suggest that activation of autophagy RGCs after
chronic elevation of IOP plays a role in cell death (Park et al., 2012).
Ultrastructural analysis by EM shows autophagosomes accumulation in dendrites and cytoplasm of RGCs in a chronic hypertensive
glaucoma model with a concomitant upregulation of LC3II and
Beclin-1. Inhibition of autophagy by 3-methyladenine (3-MA) decreases apoptosis. The authors suggest that autophagy may be
compartmentally regulated since it is initially activated in dendrites
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of the RGC and then in the cytoplasm. They propose that IOP ﬁrst
activates dendritic autophagy in response to stress in the early
stages, and later stages leads to a cytoplasmic autophagy resulting
in death. However it is important to note that not all TUNEL positive
RGCs are autophagic suggesting an alternative mechanism of cell
death after IOP elevation. Clearly, the response of autophagic
pathways needs to be taken into account when assessing the
effectiveness of other neuroprotective approaches.
Although RGCs are thought to be the ﬁnal target in glaucoma,
other cell types including glial cells also play a role. Using an IOP rat
model Tezel et al. (2012a, 2012b) document astrocyte mediated
inﬂammatory processes in glaucoma (Tezel et al., 2012b). In a global
proteomic proﬁle, the authors demonstrate upregulation of mTOR,
Atg3, and Atg7 proteins, and a phosphorylation-mediated activation of mTOR, in astrocytes and not RGCs of ocular hypertensive
rats. IRGM (immunity-related autophagy) protein expression is also
increased. This suggests properly functioning autophagy helps to
prevent glial cell death, and aberrant autophagy may contribute to
immunogenic neurodegenerative disease. Whether autophagy has
parallel roles in astrocytes and RGCs at different time points after
IOP elevation is an important issue for future studies.
5. RPE and photoreceptors
Retinal pigment epithelia serve numerous diverse functions in
the maintenance of retinal homeostasis; they transports nutrients
and ions between the retina and the choriocapillaris, serve as a
protective barrier and prevent photo-oxidative product toxicity
through the daily phagocytosis and digestion of photoreceptor
outer segment (POS) (Kevany and Palczewski, 2010). This renewal
of POSs is critical for the maintenance of photoreceptor structural
integrity and function (La Vail, 1976). Retinal degenerative diseases
due to both genetic and cumulative environmental factors lead to a
pleiotropic series of phenotypes often linked by the accumulation
of partially digested phagocytic debris in the form of lipofuscin. The
age-related increase in lipofuscin accumulation that occurs in a
wide variety of highly metabolically active, post mitotic cells
throughout the body is proposed to be the result of autophagydependent removal of damaged organelles and their subsequent
degradation in autolysosomes. Autophagy is proposed to protect
the retina from light-induced degeneration (Chen et al., 2013) with
a non-canonical form of autophagy likely involved in maintaining
the visual cycle (Kim et al., 2013). Autophagic processes play several
different, but mutually complimentary roles in photoreceptor and
RPE cells. In photoreceptors, autophagy is involved in maintaining
inner segment turnover, photoreceptor survival, and autophagydependent apoptosis. Within RPE cells, autophagy is involved in
aspects of development, cell survival in response to stress, melanin
degradation, as well as the degradation of toxic cellular components/damaged organelles.
5.1. Autophagy in the RPE
Numerous studies in a variety of cell types suggest that autophagy is linked to aging through its role in the degradation and
recycling of protein aggregates and damaged organelles (Choi et al.,
2013a; Couve et al., 2013; Pyo et al., 2013; Zhu et al., 2013). Like
most other cells, the RPE maintains basal autophagy for cellular
homeostasis, with autophagic variations common in aging and
diseased cells (Kaarniranta et al., 2013; Krohne et al., 2010; Mitter
et al., 2012). RPE cells are constantly exposed to environmental
stresses including high levels of light as well as internal stresses
due in part to their post-mitotic nature. Defects in the ability to
protect cells from such damage results in compromised homeostasis, loss of function and eventually cell death. Age-related

macular degeneration (AMD) is the leading cause of irreversible
blindness in the developed world. AMD is a progressive eye disease
that results in loss of central vision and is characterized by abnormalities in RPE cells such as a build-up of debris known as lipofuscin in lysosomes, and thickening of the Bruch’s membrane
(BM), caused by drusen deposits. Abnormal autophagy has been
cited as an important feature in the pathogenesis of AMD and other
blinding retinal diseases due to defective lysosomal-autophagic
degradation in the RPE.
The RPE is a post-mitotic phagocyte, therefore optimal
degradation of both ingested and intracellular components is
essential for cell function. Early studies by Burke and Skumatz
(1998), identiﬁed auto-ﬂuorescent debris in long-term post
conﬂuent cultures of human donor RPE cells (Burke and Skumatz,
1998). Morphometric and spectral studies suggested that the
accumulated debris likely derives from two sources, heterophagy
of photoreceptor outer segments (POS) as well as defects in
constitutive macroautophagy. It is important to note that understanding the relative contribution of each pathway is critical
given that numerous studies have shown that RPE cells accumulate autoﬂuorescent granules with many of the features of
lipofuscin in the absence of a photoreceptor substrate (Boulton
et al., 1989; Burke and Skumatz, 1998; Krohne et al., 2010; Kurz
et al., 2009). Thus basal autophagy likely also contributes to
lipofuscin-like debris.
Bergmann et al. (2004) observed reduced autophagic sequestration of endogenous proteins in cultured RPE cells. The decreased
protein degradation was followed using autoradiography in the
presence of autophagic inhibitors, further conﬁrming an essential
role for this degradative process in RPE health (Bergmann et al.,
2004). The aging RPE is also associated with decreased ATP levels,
suggested by some to contribute to reduced autophagy and POS
uptake (Schutt et al., 2013, 2012). Drusen in AMD donor eyes contains autophagic proteins and markers of exosomes, which are also
found in the Bruch’s membrane (BM) of aged mice (Wang et al.,
2009a, 2009b). To understand the molecular relationship between autophagy and exosomes, RPE cultures were treated with
rotenone (an inhibitor of mitochondrial complex 1) which did not
alter their phagocytic activity but instead resulted in elevated LC3II/
LC3 with a concomitant increase in Atg5eAtg12 conjugates.
Concurrently, Wang and coworkers observed a decrease in lysosome function and an increase in exocytic activity as well as chemoattractant release. The exosomes released by the stressed RPE
were coated with C3 complement suggesting that they are a potential target for complement factor H (CFH), mutations of which
have been linked to AMD (Loyet et al., 2012). The authors speculate
that in fact autophagy is increased in the aged RPE and exosome
release by the aged RPE contributes to drusen formation with the
aged RPE/choroid serving to recruit complement factor H. This
apparent contradiction reinforces the need to analyze autophagic
protein degradation, and not simply autophagy protein levels, to
determine if in fact autophagy is enhanced or inhibited in the aged
or diseased retina.
Lipid peroxidation products have long been known to affect
lipofuscinogenesis (Kopitz et al., 2004). The addition of HNE or
MDA-modiﬁed POS to RPE cells in vitro not only results in the
accumulation of auto-ﬂuorescent lipofuscin-like granules (Krohne
et al., 2010) but also contributes to decreased autophagic activity,
as measured by turnover of metabolically labeled endogenous
proteins in ARPE19 cells. While these studies suggest that lipid
peroxidation may contribute to defects in autophagy resulting in
accumulation of toxic lipid debris, it would be beneﬁcial to conﬁrm
this result in primary RPE cells. Collectively, these studies reinforce
the emerging notion that autophagic dysfunction contributes to
impaired RPE cell function.
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In an in vivo postnatal mitochondrial oxidative phosphorylation
ablation study, in which RPE cells lost mitochondrial oxidative
phosphorylation capacity, RPE cells where shown to dedifferentiate. In these studies activation of the AKT/mTOR pathway was
shown to drive this dedifferentiation phenotype (Zhao et al.,
2011a). A similar dedifferentiation proﬁle was observed upon
chemical oxidative damage with the enhancement of autophagy by
rapamycin serving to inhibit dedifferentiation thereby aiding in the
preservation of photoreceptors. These results reveal an in vivo
response of the mature RPE to diverse stressors that utilizes autophagy to prolong RPE cell survival. The authors conclude that mTOR
pathway inhibition may be a potential therapeutic strategy for
retinal degenerative diseases involving RPE stress. Consistent with
this notion, Zhao et al. (2011b) document age-related retinopathy in
the NRF-2 deﬁcient mouse; NRF-2 is a transcription factor with a
role in retinal antioxidant and detox response. They suggest dysregulated autophagy as a likely mechanistic link between oxidative
injury and inﬂammation proposing that the Nrf2/ mouse is a
useful model for AMD mechanistic research (Zhao et al., 2011b).
Photo-stress in the form of UVB irradiation also leads to
increased LC3II levels in a dose-dependent manner suggesting an
induced autophagic response (Li et al., 2013). Interestingly these
studies also suggest that epigallocatechin-gallate (EGCG), a polyphenol found in green tea reduces LC3II and autophagosome
number thereby repressing autophagy. Rapamycin inhibits this
effect suggesting that an Ulk1 dependent, mTOR mediated pathway
is involved. The authors suggest EGCG could be used as a potential
therapeutic agent for the treatment of eye diseases associated with
abnormal autophagy. It would perhaps be of interest to conﬁrm this
result in primary RPE cells and not simply ARPE-19 cells, an RPE cell
model known to potentially contain differentiation defects
(Ahmado et al., 2011).
Within the RPE, melanosomes provide protection against photooxidative stress (Peters and Schraermeyer, 2001; Pilat et al., 2013;
Sarangarajan and Apte, 2005; Sarna et al., 2003; Schraermeyer
and Heimann, 1999; Sundelin et al., 2001), with the accumulation
of lipofuscin in melano-lysosomes over time. Using the rhesus
monkeys, a species shown to have numerous AMD-like phenotypes, Gouras et al. (2011), show that melanosomes decrease with
age and smaller melanosomes become more common on the
basolateral side of the RPE. Among these small melanosomes they
identify an organelle in various stages of losing melanin and in
some cases nearly devoid of melanin. They suggest this unique type
of organelle, designated the ‘type 1 lysosome’, is an autophagic
melano-lysosome due to the self-degradation of melanin. In
contrast the ‘type 2 lysosome’ is rarely found without melanin
(Gouras et al., 2011). The authors report that the levels of each type
of lysosome differentially change with age, with the type 1 lysosome decreasing and type 2 lysosomes building up with age, suggesting the lysosomal and autophagic pathways are involved in
melanin decline and the pathogenesis of AMD. These seminal
studies are largely based on EM and organelle quantitation and
would be strengthened with reliable biochemical analysis.
Phagocytic cells have also evolved a novel hybrid degradative
pathway utilizing aspect of two highly conserved digestion processes, phagocytosis and autophagy. The capacity of phagocytic
cells to breakdown ingested material is predicted to be increased
through this hybrid process known as microtubule-associated
protein 1 light chain 3 (LC3) associated phagocytosis (LAP) in
which LC3 is recruited to phagosomes (Florey et al., 2011; Florey
and Overholtzer, 2012; Henault et al., 2012; Martinez et al., 2011;
Sanjuan et al., 2007, 2009). LC3 recruitment to maturing phagosomes occurs in an Atg5 dependent, Ulk1 independent manner.
Kim et al. (2013) looked at the role of autophagy in POS degradation
suggesting that the circadian burst of RPE phagocytosis coincides
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with LC3 lipidation. They report that Atg5 and Beclin1 are involved
in association of RFP-LC3 with POS but not the autophagy initiation
complex containing Ulk1. We propose that the extent of LC3 association with phagosomes is regulated by the intracellular sorting
protein melanoregulin (MREG) (Damek-Poprawa et al., 2009) as
illustrated in Fig. 2A, through an LC3 interacting region LIR
(Popovica et al., 2012) (see Fig. 2B). We have previously shown that
loss of MREG leads to the accumulation of phagosomes and an
abundance of the toxic photoproduct, A2E in older mice (DamekPoprawa et al., 2009). Given that the majority of phagosomes do
not associate with endogenous LC3, LAP may in a manner analogous to macrophages, be required to clear debris during stress
conditions or as the RPE ages (Sanjuan et al., 2007, 2009). Because
LC3 association with phagosomes is independent of autophagosome formation, additional studies are required to understand the
relative contribution of LAP to RPE mediated phagocytic processing
of ingested OS under normal and disease states, as well as the
balance between autophagic clearance of cytoplasmic material and
phagocyte maturation. Both autophagy and phagocytosis are
lysosome-mediated waste clearance pathways, in which acidiﬁcation of the endo-lysosomal system is modulated by the V-ATPase
proton pump (Oczypok et al., 2013; Valapala et al., 2014). Recent
studies by Valapala et al. (2014), show that CRYBA1/bA3/A1 crystalin is not only an RPE lysosome associated protein but that it also
modulates V-ATPase and ultimately the terminal degradation
phase of autophagy (Valapala et al., 2014). Thus not only are
autophagy and phagocytosis linked at the level of LC3 but at the
degradation phase through sorting of V-ATPase.
5.2. Autophagy in photoreceptors
The presence of misfolded proteins has been linked to numerous
diseases, including cystic ﬁbrosis, as well as neurodegenerative
diseases such as Huntingtons and Parkinson’s Disease (Bross et al.,
1999; Gilbert et al., 1998; Goldberg, 2003; Gregersen, 2006). The
accumulation of misfolded or aggregated proteins is also associated
with retinopathies including, Retinitis Pigmentosa, Best vitelliform
macular dystrophy, and Stargardt’s disease (Allikmets et al., 1997;
Burgess et al., 2008; Kaushal, 2006).
Early studies by Reme and coworkers suggested that rhodopsincontaining discs are removed by an autophagy-like process in
response to an increase in light intensity (Reme et al., 1984, 1999).
This maintains steady state levels of wild-type rhodopsin in the
photoreceptor (PR) and may therefore be important in preventing
retinal pathologies. Consistent with the work of Reme and coworkers, Iwasaki and Inomata (1988) report that lipofuscin granules are found in the myoids of inner segments with vacuoles
related to autophagy found in the myoids of rods and cones
(Iwasaki and Inomata, 1988). They speculate that lipofuscin granules are an accumulation of residual bodies of autophagy in
photoreceptor inner segments.
In a detailed molecular analyses of the role of autophagic processes in photoreceptor degeneration, rapamycin was shown to
decreases the level of mutant P23H opsin, associated with Retinitis
Pigmentosa (RP), with the autophagic proteins, Atg7, LC3 and
LAMP-1 shown to colocalize with P23H opsin (Kaushal, 2006).
Based on these ﬁndings Kaushal (2006) suggest that rapamycin (as
an autophagy enhancer) may be useful in clearing misfolded proteins associated with retinal degeneration. Consistent with a protective role for autophagy against PR cell death Besirli et al. (2011)
suggest that autophagy activation in the injured PR, inhibits Fasmediated apoptosis (Besirli et al., 2011). Here, RetinaeRPE separation results in an increase in Atg5 and LC3 as well as the lysosomal
enzymes, Cathepsin-B and Cathepsin-D. Inhibition of autophagy
through treatment with 3-methyladenine (3-MA) or through ATG5

62

L.S. Frost et al. / Experimental Eye Research 124 (2014) 56e66

Fig. 2. LC3 associated phagocytosis. A. Schematic representation of the proposed role of LC3 associated phagocytosis and MREG in the degradation of ingested POS as well as
oxidized POS. B. Schematic of the intracellular sorting protein, melanoregulin (MREG), the C-terminal palmitoylation site is indicated in blue (Wu et al., 2012) and the LC3
interacting region (LIR), residues 87e90 in red (Popovica et al., 2012).

knockdown accelerated caspase 8 activation and photoreceptor
TUNEL suggesting autophagy plays a protective role against
photoreceptor demise in response to injury.
In contrast, Kunchithapautham and Rohrer (2007) demonstrate
that apoptotic and autophagic genes may be co-expressed in PRs
undergoing degeneration (Kunchithapautham and Rohrer, 2007).
They suggest that autophagy participates in photoreceptor cell
death possibly by initiating apoptosis. These studies open the door
to the identiﬁcation of upstream regulators of autophagy as potential therapeutic targets in PR degeneration. Consistent with this,
Lohr et al. (2006) report caspase and non-caspase dependent
mechanisms contribute to PR cell death with apoptosis, autophagy
and complement mediated lysis all playing a role (Lohr et al., 2006).
Giansanti et al. (2013) reconcile these seemingly inconsistent

viewpoints and show that autophagy may play an initial survival
role, but eventually becomes impaired (as indicated by p62 accumulation) resulting in cell death (Giansanti et al., 2013). The work of
Cho and coworkers supports this idea; Cho et al. (2012) ﬁnd that
treatment of RPE-derived, ARPE19 cells and photoreceptor-derived,
661W cells, with tamoxifen results in an increase in LC3II and
autophagic ﬂux within 1 h. Death occurs by 18 h suggesting that
autophagy plays an initial protective role in these cells, however
the autophagic process becomes impaired over time leading to
eventual cell demise (Cho et al., 2012).
Autophagy may also play diverse roles in rod and cone photoreceptors with the addition of rapamycin having differing effects on
rods and cones in an albino mouse light damage model
(Kunchithapautham et al., 2011). Rapamycin treatment improves
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Fig. 3. Alterations in autophagy in various regions of the eye. Schematic of the anatomy of the eye with Tables displaying autophagy proteins affected in various regions, some
leading to ocular disease.

rod photoreceptor survival and function, reduces apoptosis and
normalizes cytokine levels that were elevated by light. However,
Kunchithapautham and coworkers report that autophagic vacuole
(AV) formation is seen exclusively in cones with concomitant
reduction in cone photoreceptor function. This suggests the rapamycin acts differentially in stressed PRs. The authors speculate that
AV-dependent autophagy may require photon capture in cone PRs,
which is consistent with the work of Reme et al. (1999) who
demonstrate that AVs are generated in response to intense light and
may be involved in shortening POSs to reduce photon capture.
Kunchithapautham et al. (2011) also suggest that autophagy may
play a role in apoptosis either by delaying it, or by initiating it,
consistent with previous studies.
In a recent series of studies, Chen et al. (2013) sought to determine if autophagy serves a protective role in light induced degeneration in rod cells (Chen et al., 2013). Using the Abca4/Rdh8/
mouse, which exhibits delayed clearance of all trans retinal they
demonstrate increased expression of LC3II as well as the mitophagy
speciﬁc regulator Park2 in response to light. They go on to directly
address the role of autophagy, speciﬁcally at the induction stage in
light induced cell death using a beclin 1þ/ mouse (the beclin-1/ is
embryonic lethal) as well as a rod speciﬁc Atg7 knockout mouse.
Both Atg7 and beclin1 are necessary in the induction phase of

autophagosome formation. Rod cell morphology in the beclin 1þ/
mouse was normal under room light however under intense light
these mice developed severe retinal degeneration; whereas the rod
speciﬁc decrease in Atg7 resulted in retinal degeneration even
under normal light. These studies led these authors to suggest that
under relatively mild stress autophagy is activated to cope with this
cellular stress whereas impaired autophagy is associated with
increased stress ultimately contributing to cell death. Clearly the
relationship between impaired autophagy and cell death need to be
elucidated in this model. The studies by Chen et al. (2013) are even
more provocative when coupled with the work of Kim et al. (2013),
who show that a non-canonical form of autophagy is utilized by
RPE cells in POS phagocytosis to maintain the visual cycle (Kim
et al., 2013). These two studies underscore the need to address
the role of autophagy in vivo when possible given the complexity of
photoreceptoreRPE interactions necessary for POS renewal and
visual pigment recycling.
6. Summary
Although often labeled as a degradative process, autophagy can
be considered a recycling pathway; it is in this context that we best
understand its cytoprotective role and contribution to cell
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homeostasis. Metabolites generated through autophagic processes
are used for energy or re-used as building blocks in the synthesis of
new macromolecules. In an analysis of autophagic pathways in the
maintenance of cell health some common themes emerge
including the role of autophagy in post-mitotic cells the interplay
between autophagy and apoptosis two process that both focus on
“self-consumption” and in the case of photoreceptors the recycling
of visual pigments. A summary of alterations in autophagy in
various regions of the eye displaying autophagy proteins, some
leading to ocular disease is shown for reference in Fig. 3.
The post-mitotic nature of the lens ﬁber cells, RGCs, photoreceptor cells, and the RPE cells puts them at an elevated risk for
demise through a defective autophagic pathway. As with other post
mitotic cells residual material resulting from impaired clearance
slowly accumulates within and around these cells throughout life.
Lens ﬁbers cells maintain transparency by preventing the build-up
of cellular waste and misfolded proteins through autophagy. The
RPE maintains normal morphology and function through regulated
basal autophagy as well as newly described role of autophagy in
phagocytosis (Kim et al., 2013). Autophagy is a key pathway by
which these cells sequester toxic waste and target it for degradation by lysosomes. Defects in any stage of autophagosome formation (reviewed in Fig. 1), autophagic vacuole trafﬁcking or
association and fusion with lysosomes will disrupt this “cleaning”
function thereby contributing to the build-up of toxic debris. Such
debris is often in the form of Pick or Lewy bodies. It is likely that
mutations in autophagy genes could be a contributing factor to
susceptibility to cataracts or AMD.
Autophagy is thought to play a dual role in cell survival and cell
death (Chaabane et al., 2013; Eskelinen, 2005; Levine and Yuan,
2005; Subramani and Malhotra, 2013; Yu et al., 2004). Photoreceptor death is proposed to occur mainly through apoptotic
mechanisms. Consistent with this, models of retinal degenerations
show the caspase family of cysteine proteases is elevated
(Murakami et al., 2013; Zacks et al., 2003, 2004). However, recent
evidence suggests non-apoptotic forms of cell death such as autophagy and necrosis may play a role (for review see Murakami et al.,
2013). In both photoreceptors and RGCs, it appears that the interplay between autophagy and apoptosis is critical for cell health. The
interrelationship between these two processes both considered by
some as mechanisms of programmed cell death is complex (Marino
et al., 2014). One commonality between RGCs and photoreceptor
cells is that autophagy and apoptosis often occur in the same cell,
with autophagy preceding apoptosis. This sequence of events is
likely due to the fact that stress will stimulate the autophagic
response up until a point when that level of stress, whether due to
time or dose, becomes lethal. These cells appear to utilize autophagy as a cytoprotective mechanism unless or until a critical stress
threshold or duration is exceeded at which point apoptotic mechanism are activated. Once activated apoptosis inactivates autophagy in part due to the inactivation of autophagy proteins by
caspase cleavage. Thus it is critical both in advancing our understanding of glaucoma as well as AMD that we deﬁne those factors
that regulate that critical threshold; we determine how genetic
predisposition alters the precarious balance between autophagy
and apoptosis and how metabolism regulates this interrelationship.
Finally, from a technical standpoint, numerous autophagy
studies would beneﬁt from a more uniﬁed approach designed to
accurately assess autophagic ﬂux. For example, it is more appropriate to measure GFP-LC3 cleavage in the presence or absence of
chloroquine or baﬁlomycin A1 together with other autophagy
markers, such as p62 and endogenous LC3-II because the amount of
free GFP does not correlate with autophagic ﬂux if the lysosomal
activity and pH are changed (Ni et al., 2011) as is the case for
example in the Abcr4/ mouse model of Stargardt’s disease (Liu

et al., 2008). Furthermore, immunoblot quantitation of LC3 and
LC3II are not directly indicative of autophagic ﬂux (Wang et al.,
2009a). Ideally the use of in vivo models is preferred with the
analysis of endogenous levels of autophagy proteins.
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